Rachna Shroff
Overview
Explore the profile of Rachna Shroff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Piha-Paul S, Olwill S, Hamilton E, Tolcher A, Pohlmann P, Liu S, et al.
Clin Cancer Res
. 2024 Sep;
31(2):288-298.
PMID: 39235868
Purpose: 4-1BB (CD137) is a costimulatory immune receptor expressed on activated T cells, activated B cells, NK cells, and tumor-infiltrating lymphocytes, making it a promising target for cancer immunotherapy. Cinrebafusp...
2.
Shroff R, Goetzl E
Am J Med
. 2024 Jun;
137(11):1055-1058.
PMID: 38925498
Cellular protein kinases are involved in diverse normal cellular functions. Many types of dysregulation of protein kinases are the molecular basis for development of common cancers and neurodegenerative diseases. More...
3.
Azad N, Hu Z, Sahin I, Iyer R, Aranha O, Hochster H, et al.
Future Oncol
. 2024 Jun;
20(30):2241-2248.
PMID: 38861293
Treatment options for patients with biliary tract cancer are limited, and the prognosis is poor. CTX-009, a novel bispecific antibody targeting both DLL4 and VEGF-A, has demonstrated antitumor activity in...
4.
Young S, Hannallah J, Goldberg D, Khreiss M, Shroff R, Arshad J, et al.
Semin Intervent Radiol
. 2024 Jan;
40(6):515-523.
PMID: 38274222
In the past several decades, major advances in both systemic and locoregional therapies have been made for many cancer patients. This has led to modern cancer treatment algorithms frequently calling...
5.
Forman L, Sapisochin G, Assis D, Arrive L, Bergquist A, Bowlus C, et al.
Hepatology
. 2023 Feb;
77(5):E97-E98.
PMID: 36732294
No abstract available.
6.
Bowlus C, Arrive L, Bergquist A, Deneau M, Forman L, Ilyas S, et al.
Hepatology
. 2023 Jan;
77(6):E176-E177.
PMID: 36695291
No abstract available.
7.
McNamara M, Bridgewater J, Goyal L, Jacobs T, Wagner A, Goldstein D, et al.
BMJ Open
. 2022 Oct;
12(10):e064954.
PMID: 36288834
Objectives: Female physicians in medicine are increasing, but disparities in female authorship exist. The aim of this study was to characterise factors associated with female first (FF) and female senior...
8.
Bowlus C, Arrive L, Bergquist A, Deneau M, Forman L, Ilyas S, et al.
Hepatology
. 2022 Sep;
77(2):659-702.
PMID: 36083140
No abstract available.
9.
Sipra Q, Shroff R
Expert Opin Investig Drugs
. 2020 Nov;
30(4):281-284.
PMID: 33228417
No abstract available.
10.
Koay E, Katz M, Wang H, Wang X, Prakash L, Javle M, et al.
JCO Precis Oncol
. 2020 Sep;
3.
PMID: 32914036
Purpose: Effective preoperative regimens and biomarkers for pancreatic ductal adenocarcinoma (PDAC) are lacking. We prospectively evaluated fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX)-based treatment and imaging-based biomarkers for borderline resectable PDAC....